SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK

Supernus to Present at the Cowen 43rd Annual Health Care Conference

01 Mar 2023 16:55:45 By Nasdaq GlobeNewswire

Supernus Announces Fourth Quarter and Full Year 2022 Financial Results

28 Feb 2023 16:05:33 By Nasdaq GlobeNewswire

Supernus Enters Into $150 Million Credit Facility

14 Feb 2023 16:30:00 By Nasdaq GlobeNewswire

Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 28, 2023

09 Feb 2023 18:15:05 By Nasdaq GlobeNewswire

Supernus to Present at the Piper Sandler 34th Annual Healthcare Conference

22 Nov 2022 17:00:00 By Nasdaq GlobeNewswire

Supernus to Present at Two November Healthcare Conferences

08 Nov 2022 17:30:00 By Nasdaq GlobeNewswire

Supernus Announces Third Quarter 2022 Financial Results

08 Nov 2022 16:05:02 By Nasdaq GlobeNewswire

Supernus Pharmaceuticals to Announce Third Quarter 2022 Financial Results and Host Conference Call on November 8, 2022

25 Oct 2022 16:30:00 By Nasdaq GlobeNewswire

Supernus Provides Regulatory Update on SPN-830

10 Oct 2022 08:30:00 By Nasdaq GlobeNewswire

Supernus to Present at the 2022 Wells Fargo Healthcare Conference

31 Aug 2022 16:00:00 By Nasdaq GlobeNewswire

Supernus Announces Second Quarter 2022 Financial Results

04 Aug 2022 16:01:00 By Nasdaq GlobeNewswire

Supernus Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 4, 2022

25 Jul 2022 17:00:00 By Nasdaq GlobeNewswire

Supernus to Participate in the Jefferies Healthcare Conference

02 Jun 2022 16:05:00 By Nasdaq GlobeNewswire

Supernus Announces First Quarter 2022 Financial Results

09 May 2022 16:05:01 By Nasdaq GlobeNewswire

Supernus Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call on May 9, 2022

02 May 2022 16:55:00 By Nasdaq GlobeNewswire

Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults

29 Apr 2022 20:00:38 By Nasdaq GlobeNewswire

Supernus Reports Final Audited Fourth Quarter and Full Year 2021 Financial Results

13 Apr 2022 16:11:14 By Nasdaq GlobeNewswire

Supernus Provides Update on Filing of Annual Report and Reiterates Full Year 2022 Financial Guidance

04 Apr 2022 17:00:00 By Nasdaq GlobeNewswire

Supernus Notifies Nasdaq Regarding Non-Compliance with Listing Requirement and Expectation to Regain Compliance

17 Mar 2022 08:30:00 By Nasdaq GlobeNewswire

Supernus to Participate in Annual Cowen Health Care Conference

02 Mar 2022 08:00:01 By Nasdaq GlobeNewswire